StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Amgen's (AMGN) ESMO Update is a Net Positive - Credit Suisse
September 21, 2020 6:45 AM
Credit Suisse analyst Evan Seigerman reiterated an Outperform rating and $290.00 price target on Amgen (NASDAQ: AMGN) after the company ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments